HCPCS J-Codes
Drugs administered other than oral method, chemotherapy drugs

These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.


View All HCPCS Sections
  • J1620

    Injection, gonadorelin hydrochloride, per 100 mcg
  • J1626

    Injection, granisetron hydrochloride, 100 mcg
  • J1627

    Injection, granisetron, extended-release, 0.1 mg
  • J1628

    Injection, guselkumab, 1 mg
  • J1630

    Injection, haloperidol, up to 5 mg
  • J1631

    Injection, haloperidol decanoate, per 50 mg
  • J1632

    Injection, brexanolone, 1 mg
  • J1640

    Injection, hemin, 1 mg
  • J1642

    Injection, heparin sodium, (heparin lock flush), per 10 units
  • J1643

    Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units
  • J1644

    Injection, heparin sodium, per 1000 units
  • J1645

    Injection, dalteparin sodium, per 2500 iu
  • J1650

    Injection, enoxaparin sodium, 10 mg
  • J1652

    Injection, fondaparinux sodium, 0.5 mg
  • J1655

    Injection, tinzaparin sodium, 1000 iu
  • J1670

    Injection, tetanus immune globulin, human, up to 250 units
  • J1675

    Injection, histrelin acetate, 10 micrograms
  • J1700

    Injection, hydrocortisone acetate, up to 25 mg
  • J1710

    Injection, hydrocortisone sodium phosphate, up to 50 mg
  • J1720

    Injection, hydrocortisone sodium succinate, up to 100 mg
  • J1725

    Injection, hydroxyprogesterone caproate, 1 mg
  • J1726

    Injection, hydroxyprogesterone caproate, (makena), 10 mg
  • J1729

    Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
  • J1730

    Injection, diazoxide, up to 300 mg
  • J1736

    Injection, meloxicam (delova), 1 mg
  • J1737

    Injection, meloxicam (azurity), 1 mg
  • J1738

    Injection, meloxicam, 1 mg
  • J1740

    Injection, ibandronate sodium, 1 mg
  • J1741

    Injection, ibuprofen, 100 mg
  • J1742

    Injection, ibutilide fumarate, 1 mg
  • J1743

    Injection, idursulfase, 1 mg
  • J1744

    Injection, icatibant, 1 mg
  • J1745

    Injection, infliximab, excludes biosimilar, 10 mg
  • J1746

    Injection, ibalizumab-uiyk, 10 mg
  • J1747

    Injection, spesolimab-sbzo, 1 mg
  • J1748

    Injection, infliximab-dyyb (zymfentra), 10 mg
  • J1749

    Injection, iloprost, 0.1 mcg
  • J1750

    Injection, iron dextran, 50 mg
  • J1756

    Injection, iron sucrose, 1 mg
  • J1786

    Injection, imiglucerase, 10 units
  • J1790

    Injection, droperidol, up to 5 mg
  • J1800

    Injection, propranolol hcl, up to 1 mg
  • J1805

    Injection, esmolol hydrochloride, 10 mg
  • J1806

    Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg
  • J1807

    Injection, ethacrynate sodium, 1 mg
  • J1808

    Injection, folic acid, 0.1 mg
  • J1809

    Injection, fosdenopterin, 0.1 mg
  • J1810

    Injection, droperidol and fentanyl citrate, up to 2 ml ampule
  • J1811

    Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units
  • J1812

    Insulin (fiasp), per 5 units

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/3/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.